The Latest in Gastrointestinal Cancer

Cancer as a full contact sport

October 3, 2022

Could your patients benefit? New trials in noncolorectal GI cancer

September 30, 2022

Gastrointestinal Cancer

Despite benefits, extended-interval pembro uptake remains low

September 28, 2022

FDA OKs selpercatinib for adults with RET-fusion+ solid tumors

September 23, 2022

Pandemic-related CRC screening delays affect older adults most

September 22, 2022

High BMI linked to better survival for cancer patients treated with ICI, but for men only

September 22, 2022

Sugary drinks linked to obesity-related cancer deaths

September 21, 2022

Novel blood test for early-stage liver cancer shows promise

September 19, 2022

Gastrointestinal Cancer

A farewell to arms? Drug approvals based on single-arm trials can be flawed

September 19, 2022

Time to cancer diagnoses in U.S. averages 5 months

September 15, 2022

Annual screening benefits people at high-risk for pancreatic cancer

September 14, 2022

‘Unprecedented’ responses to neoadjuvant treatment in dMMR colon cancer

September 14, 2022

Gastrointestinal Cancer

First drug for desmoid tumors: ‘Impressive’ data for nirogacestat

September 13, 2022

After index colonoscopy, what’s the CRC risk in 40- to 49-year-olds vs. 50- to 59-year-olds?

September 9, 2022

Taking the heat out of coffee’s esophageal cancer risk

September 6, 2022